Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Emmanuel Nony & Philippe Moingeon. (2022) Proteomics in support of immunotherapy: contribution to model-based precision medicine. Expert Review of Proteomics 19:1, pages 33-42.
Read now
Read now
Pascal Demoly, Yoshitaka Okamoto, William H. Yang, Philippe Devillier & Karl-Christian Bergmann. (2016) 300 IR HDM tablet: a sublingual immunotherapy tablet for the treatment of house dust mite-associated allergic rhinitis. Expert Review of Clinical Immunology 12:11, pages 1141-1151.
Read now
Read now
Emmanuel Nony, Armelle Martelet, Karine Jain & Philippe Moingeon. (2016) Allergen extracts for immunotherapy: to mix or not to mix?. Expert Review of Clinical Pharmacology 9:3, pages 401-408.
Read now
Read now
Articles from other publishers (17)
Thierry Batard, Walter G. Canonica, Oliver Pfaar, Mohamed H. Shamji, Robyn E. O’Hehir, Menno C. van Zelm & Laurent Mascarell. (2023) Current advances in house dust mite allergen immunotherapy (AIT): Routes of administration, biomarkers and molecular allergen profiling. Molecular Immunology 155, pages 124-134.
Crossref
Crossref
Ludger Klimek, Randolf Brehler, Ingrid Casper, Felix Klimek, Jan Hagemann, Mandy Cuevas & Karl-Christian Bergmann. (2023) Allergen-Immuntherapie bei Hausstaubmilben-assoziierter allergischer Rhinitis: Wirksamkeit der 300 IR-Milbentablette. Allergo Journal 32:1, pages 26-35.
Crossref
Crossref
Ludger Klimek, Randolf Brehler, Ingrid Casper, Felix Klimek, Jan Hagemann, Mandy Cuevas & Karl-Christian Bergmann. (2023) Allergen immunotherapy in house dust mite-associated allergic rhinitis: efficacy of the 300 IR mite tablet. Allergo Journal International 32:1, pages 10-17.
Crossref
Crossref
Ekaterina Potapova, Véronique Bordas‐Le Floch, Thomas Schlederer, Susanne Vrtala, Huey‐Jy Huang, Giorgio W. Canonica, Rudolf Valenta, Paolo M. Matricardi & Laurent Mascarell. (2022) Molecular reactivity profiling upon immunotherapy with a 300 IR sublingual house dust mite tablet reveals marked humoral changes towards major allergens. Allergy 77:10, pages 3084-3095.
Crossref
Crossref
Akira Hasegawa, Daichi Utsumi, Kaare Lund, Mitsuhiro Okano, Katsuyo Ohashi-Doi & Kimihiro Okubo. (2022) Correlation between sensitization to house dust mite major allergens, age, and symptoms in Japanese house dust mite allergic subjects. International Immunopharmacology 107, pages 108640.
Crossref
Crossref
Irina Bucur & Florica Popescu. (2020) Pharmaceutical presentation of tablets for sublingual allergen immunotherapy available worldwide. Alergologia 2:4, pages 87.
Crossref
Crossref
Jason R. Woloski, Deepa Burman & Olumuyiwa Adebona. (2018) Mite and Bed Bug Infections. Primary Care: Clinics in Office Practice 45:3, pages 409-421.
Crossref
Crossref
Véronique Bordas-Le Floch, Maxime Le Mignon, Laetitia Bussières, Karine Jain, Armelle Martelet, Véronique Baron-Bodo, Emmanuel Nony, Laurent Mascarell & Philippe Moingeon. (2017) A combined transcriptome and proteome analysis extends the allergome of house dust mite Dermatophagoides species. PLOS ONE 12:10, pages e0185830.
Crossref
Crossref
Philippe Moingeon & Laurent Mascarell. (2017) Differences and similarities between sublingual immunotherapy of allergy and oral tolerance. Seminars in Immunology 30, pages 52-60.
Crossref
Crossref
C. Hüser, P. Dieterich, J. Singh, K. Shah-Hosseini, S. Allekotte, W. Lehmacher, E. Compalati & R. Mösges. (2017) A 12-week DBPC dose-finding study with sublingual monomeric allergoid tablets in house dust mite-allergic patients. Allergy 72:1, pages 77-84.
Crossref
Crossref
Jocelyne Just, Antoine Deschildre & Etienne Beaudouin. 2017. Allergies Alimentaires. Allergies Alimentaires
229
258
.
Pascal Demoly, Giovanni Passalacqua, Oliver Pfaar, Joaquin Sastre & Ulrich Wahn. (2016) Management of the polyallergic patient with allergy immunotherapy: a practice-based approach. Allergy, Asthma & Clinical Immunology 12:1.
Crossref
Crossref
Katherine A. Lyseng-Williamson. (2016) Standardized quality house dust mite sublingual tablets (Acarizax®): a guide to their use as sublingual allergy immunotherapy in Europe. Drugs & Therapy Perspectives 32:12, pages 502-509.
Crossref
Crossref
Katherine A. Lyseng-Williamson. (2016) House dust mite sublingual tablets (Actair®): a guide to their use as allergy immunotherapy for house dust mite-induced allergic rhinitis. Drugs & Therapy Perspectives 32:6, pages 219-225.
Crossref
Crossref
T. Batard, V. Baron-Bodo, A. Martelet, M. Le Mignon, P. Lemoine, K. Jain, S. Mariano, S. Horiot, H. Chabre, C. Harwanegg, C. A. Marquette, B. P. Corgier, W. T. Soh, P. Satitsuksanoa, A. Jacquet, F. T. Chew, E. Nony & P. Moingeon. (2016) Patterns of IgE sensitization in house dust mite-allergic patients: implications for allergen immunotherapy. Allergy 71:2, pages 220-229.
Crossref
Crossref
Moisés A. Calderón, Jörg Kleine-Tebbe, Allan Linneberg, Frédéric De Blay, Dolores Hernandez Fernandez de Rojas, Johann Christian Virchow & Pascal Demoly. (2015) House Dust Mite Respiratory Allergy: An Overview of Current Therapeutic Strategies. The Journal of Allergy and Clinical Immunology: In Practice 3:6, pages 843-855.
Crossref
Crossref
Wai Tuck Soh, Maxime Le Mignon, Narissara Suratannon, Pattraporn Satitsuksanoa, Pantipa Chatchatee, Jongkonnee Wongpiyaboron, Mukda Vangveravong, Ticha Rerkpattanapipat, Atik Sangasapaviliya, Emmanuel Nony, Surapon Piboonpocanun, Kiat Ruxrungtham & Alain Jacquet. (2015) The House Dust Mite Major Allergen Der p 23 Displays O-Glycan-Independent IgE Reactivities but No Chitin-Binding Activity. International Archives of Allergy and Immunology 168:3, pages 150-160.
Crossref
Crossref